<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00238082</url>
  </required_header>
  <id_info>
    <org_study_id>HS-1277</org_study_id>
    <nct_id>NCT00238082</nct_id>
  </id_info>
  <brief_title>The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>The Effect of HFA-beclomethasone Dipropionate on Static Lung Volumes in COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Jewish Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Jewish Health</source>
  <brief_summary>
    <textblock>
      This is an investigator-sponsored research study to evaluate if treatment with HFA-134a
      beclomethasone (QVAR) has an effect on peripheral (or outer) airway inflammation and airway
      &quot;remodeling&quot; or scarring in subjects with COPD. Approximately 20 subjects with COPD will
      participate for approximately 7 weeks, with 10 receiving an active (BDP) inhaler with
      HFA-134a and 10 receiving a placebo.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">November 1999</start_date>
  <completion_date type="Actual">February 2005</completion_date>
  <primary_completion_date type="Actual">February 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spirometric response (FEV1)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung volumes such as residual volume (RV), thoracic gas volume, total lung capacity (TLC) and the RV/TLC ratio</measure>
  </primary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>COPD</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HFA-134A Beclomethasone DIpropionate (QVAR)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD diagnosis

          -  FEV1/FVC&lt;70%

          -  FEV1 50-80% predicted

          -  Albuterol response of &lt;12% and &lt;200mL or methacholine PC20 &gt; 8mg/mL

          -  RV &gt; 120% predicted

          -  DLCO &lt; 80%

          -  smokers and nonsmokers

          -  Lower age limit 45 years

        Exclusion Criteria:

          -  Asthma

          -  Other chronic airway or parenchymal lung disease

          -  Other comorbid illness (including but not limited to DM, MI or CAD-related
             intervention in 6 months, neurologic disease, syncope)

          -  Use of any steroid (oral, IV, nasal, pulmonary) within 12 weeks

          -  Use of theophylline, leukotriene modifiers within 12 weeks

          -  Use of long-acting beta-agonists (formoterol, salmeterol) or anticholinergic
             (tiotropium)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Martin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Jewish Medical and Research Center faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Jewish Medical and Research Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nationaljewish.org/programs/directory/copd/</url>
    <description>clinical lab website within National Jewish Medical and Research Center</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2005</study_first_submitted>
  <study_first_submitted_qc>October 11, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2005</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <keyword>COPD</keyword>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Chronic Bronchitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Beclomethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

